-
Most Popular
Search Results
240 results for art
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?
Dexcom’s Stelo faces an uncertain future thanks to drugs like Wegovy and a competing Abbott Labs product. DXCM stock is down 40% today.
3 High-Growth Stocks Trading at Fair Value
High-growth stocks trading at fair value are rare these days, but they do exist and deserve investor consideration overall.
3 Breakthrough Stocks Under $10 Set for Massive Upside
Discover the top breakthrough stocks under $10 with strong fundamentals and strategic advantages to hit massive upside.
3 Infrastructure Stocks Positioned for Potential Government Spending
See how these infrastructure stocks are set to benefit from the infrastructure boom fueled by government spending.
3 Blockchain Stocks to Add to Your Must-Watch List in July 2024
These blockchain stocks deserve a place on your must-watch list as the cutting-edge technology intersects with promising market opportunities.
“Everyone Knows” AGI Is Coming… but How to Prepare?
Everyone correctly knows that AI is here to stay and that artificial general intelligence (AGI) is coming. But few know the best way to survive……
Get Your Money Out of These 3 REITS by 2025
Explore reasons to consider divesting from these REITs to sell by 2025 due to sector-specific challenges and high debt levels.
The 7 Best Under $20 Stocks to Buy in August 2024
Although cheap stocks are often cheap for a reason, it doesn’t hold true for the best stocks under $20, which is where investors can profit.
7 Stock Picks for Brazen Short Sellers Seeking Overnight Riches
These short selling stock picks are high on short interest and high with potential to turn brazen investors into overnight millionaires.
ATR Stock Earnings: AptarGroup Beats EPS, Misses Revenue for Q2 2024
ATR stock results show that AptarGroup beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
GOOG Stock Risk: How Probes and AI Scrutiny Could Shape Alphabet’s Future
Explore potential impacts of increasing regulatory scrutiny on Alphabet stock and other tech giants, particularly in Europe.
3 Hydrogen Stocks to Buy on the Dip: July 2024
Concerns of a repeal of the Inflation Reduction Act have been overblown, creating opportunity for green stocks, including hydrogen stocks.
7 Leading MedTech Stocks for Next-Gen Health Solutions
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.
Q3’s Rising Stars: 8 Dividend Stocks for Your Must-Watch List
These seven dividend stocks to watch can enhance your portfolio’s return by providing both growth and income.
Why Is NLS Pharmaceutics (NLSP) Stock Up 48% Today?
NLS Pharmaceutics stock is up on Monday after the company provided NLSP investors with details on a merger deal with Kadimastem.
Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today?
Cognition Therapeutics stock is down on Monday after CGTX investors read the latest data from a Phase 2 clinical trial report.
3 EV Stocks to Sell Before JD Vance Tanks the Sector
Investors may want to keep an eye on these EV stocks to sell in the event of a Trump-Vance ticket victory in November.
The 3 Best Data Center Stocks to Buy Now: July 2024
The best data center stocks might be obvious to most investors but there is always a diamond in the rough or two.
3 Stocks to Load-Up On Before Autumn Arrives
These stocks to buy for autumn have been great long-term winners for shareholders and are likely to rise again.
3 High-Yield Dividend Stocks That Are Looking Super Hot
Discover High-Yield Dividend Stocks offering solid returns. Learn about AbbVie, Target, and Abbott for reliable income and growth potential.
Intel Layoffs 2024: What to Know as INTC Plans to Slash Thousands of Jobs
Intel is planning on laying off thousands of jobs according to Bloomberg. The chipmaker has struggled to compete against its peers.
3 Stocks That Could See Increased Demand Thanks to the CrowdStrike Outage
The CrowdStrike outage caused IT systems worldwide to go down but opened up opportunities for rivals to take share from the market leader.
8 – 10 of 240 results
